首页> 外国专利> METHOD OF ENDOVITREAL TREATMENT OF RHEGMATOGENOUS RETINAL DETACHMENT

METHOD OF ENDOVITREAL TREATMENT OF RHEGMATOGENOUS RETINAL DETACHMENT

机译:内镜治疗血源性视网膜脱离

摘要

FIELD: medicine.;SUBSTANCE: invention relates to medicine, specifically to ophthalmology. For surgical treatment of rhegmatogenous retinal detachment combined with posterior vitreous detachment, three punctures are made in flat part of ciliary body, subtotal vitrectomy, substitution of physiological solution and endolaser coagulation of retina around rupture. During the vitrectomy, the periphery and the retinal rupture area are scrapped with sclerocompression. That is followed by physiological solution replacement with air to the level of rupture and aspiration of the subretinal liquid in the air. Remaining physiologic solution is removed from vitreal cavity, endolaser coagulation of retina around rupture is performed with sclerocompression. Operation is completed by gas-air tamponade and removal of ports.;EFFECT: method enables intraoperative complete adhesion of eyeballs, excludes the need for introduction into the vitreous cavity of PFOC, and therefore reduces injuries by eliminating all possible complications associated with its use, time of surgical intervention.;1 cl, 2 ex
机译:技术领域本发明涉及医学,尤其涉及眼科。对于流变性视网膜脱离合并玻璃体后脱离的外科手术治疗,在睫状体的扁平部分进行三处穿刺,玻璃体切除术,更换生理溶液以及破裂周围视网膜的激光内凝结。在玻璃体切除术中,巩膜压缩压迫了周围和视网膜破裂区域。随后,用空气生理溶液替代至空气中视网膜下液的破裂和抽吸水平。从玻璃体腔中去除剩余的生理溶液,通过巩膜压缩术进行破裂周围视网膜的激光内凝。手术通过气垫填塞和去除端口来完成。效果:该方法可在术中使眼球完全粘连,无需将其引入PFOC的玻璃体腔中,从而通过消除与使用相关的所有可能的并发症来减少伤害,手术时间:1 cl,2 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号